View all studies | Genital Herpes Vaccine

Genital herpes is a common sexually transmitted infection (STI) caused by the herpes simplex virus (HSV). Genital herpes can often be spread by skin-to-skin contact during sexual activity. Some people infected with the virus may have very mild symptoms or no symptoms, however, they may still be able to spread the virus. Other people have pain, itching and sores around the genitals or anus.  

This research study is evaluating the safety and immune response of an investigational herpes vaccine to potentially help prevent genital herpes lesions.

 The study may be an option if you:
·     Are aged 18-55 years old
·     Have a diagnosis of recurrent genital herpes
·     Have had between 3 to 9 genital herpes recurrences in the last year.
Other criteria apply.
 
This research study will include 11 scheduled visits to the clinic site and 6 phone calls. Qualified participants may receive the vaccine and will receive study-related evaluations and care at no cost. Financial compensation will also be provided for time and travel expenses to qualified participants.

Submit to learn more:

**By registering and providing your telephone number, you agree to receive text messages from Accellacare for the purposes above at the number you provide. Message and data rates may apply. Message frequency will vary. No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. For help, reply HELP to any message. To opt-out, reply STOP to any message.

When you register your interest with Accellacare (which is part of ICON plc), our team will add your information to our database, review your information and connect you with studies that you may be eligible for. When we find a match, Accellacare clinical research specialists will contact you directly for further pre-screening by phone and may refer you on to Accellacare sites or collaborating third-party sites for further on-site pre-screening. We may also contact you in the future by phone call, text message, or email regarding future trials you may be interested in based on the information you provide to us. The clinic you choose in the registration form below may be a third-party study site (which will be clearly indicated) that collaborates with Accellacare on clinical trials. If you select a third-party site, you agree that we may share your personal data with that clinic for further pre-screening. That clinic will be independently responsible for processing your personal data in accordance with all applicable data protection laws.

Data Protection

ICON plc is responsible for the personal data, including data related to your health, race, and ethnicity you choose to provide. We rely on your consent to add your information to our database, use this information to identify potentially appropriate clinical studies for you and contact you about them. When we call you for further pre-screening, note that these calls will be recorded. If you have selected a third-party site, we will share your information with this site so they can contact you for further pre-screening.

Please enter the security code:


Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.